Skip to main navigation Skip to search Skip to main content

Correction to: Predicting survival in melanoma patients treated with concurrent targeted- or immunotherapy and stereotactic radiotherapy (vol 15, 135, 2020): Melanoma brain metastases prognostic score

  • Jana Schaule
  • , Stephanie G C Kroeze
  • , Oliver Blanck
  • , Susanne Stera
  • , Klaus H Kahl
  • , Falk Roeder
  • , Stephanie E Combs
  • , David Kaul
  • , An Claes
  • , Markus M Schymalla
  • , Sonja Adebahr
  • , Franziska Eckert
  • , Fabian Lohaus
  • , Nasrin Abbasi-Senger
  • , Guido Henke
  • , Marcella Szuecs
  • , Michael Geier
  • , Nora Sundahl
  • , Daniel Buergy
  • , Reinhard Dummer
  • Matthias Guckenberger

Research output: Contribution to journalComment/Letter to the editorAcademicpeer-review

5 Downloads (Pure)

Abstract

An amendment to this paper has been published and can be accessed via the original article. Predicting survival in melanoma patients treated with concurrent targeted- or immunotherapy and stereotactic radiotherapy: Melanoma brain metastases prognostic score (Radiation Oncology, (2020), 15, 1, (135), 10.1186/s13014-020-01558-8)

Original languageEnglish
Article number280
Pages (from-to)1-2
JournalRadiation Oncology [E]
Volume15
Issue number1
DOIs
Publication statusPublished - 14 Dec 2020

Fingerprint

Dive into the research topics of 'Correction to: Predicting survival in melanoma patients treated with concurrent targeted- or immunotherapy and stereotactic radiotherapy (vol 15, 135, 2020): Melanoma brain metastases prognostic score'. Together they form a unique fingerprint.

Cite this